FTH ▲ +2.4% - Faeth Therapeutics, Inc. $FTH Faeth Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate PIKTOR in Combination with a Selective Estrogen Receptor Degrader in HR+/HER2- Advanced Breast Cancer 16-NOV-2026 07:01 AM ET